{"id": "article-71_0", "title": "Cholestyramine Resin  -- Continuing Education Activity", "content": "Cholestyramine is used for the treatment of primary hypercholesterolemia. The reduction in LDL cholesterol by the resin is dose-dependent. A dose of 8 to 12 grams of cholestyramine is associated with a 12% to 18% reduction in LDL cholesterol. It also reduces the risk of coronary artery disease. Cholestyramine can be used in patients with bile-acid diarrhea or choleretic enteropathy due to limited ileal disease or resection. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of cholestyramine that is pertinent information for interprofessional team members when lipid-lowering therapy is indicated.", "contents": "Cholestyramine Resin  -- Continuing Education Activity. Cholestyramine is used for the treatment of primary hypercholesterolemia. The reduction in LDL cholesterol by the resin is dose-dependent. A dose of 8 to 12 grams of cholestyramine is associated with a 12% to 18% reduction in LDL cholesterol. It also reduces the risk of coronary artery disease. Cholestyramine can be used in patients with bile-acid diarrhea or choleretic enteropathy due to limited ileal disease or resection. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of cholestyramine that is pertinent information for interprofessional team members when lipid-lowering therapy is indicated."}
{"id": "article-71_1", "title": "Cholestyramine Resin  -- Continuing Education Activity", "content": "Objectives: Identify the mechanism of action of cholestyramine. Outline the approved and potential indications of cholestyramine. Recall the potential side effects/adverse events of cholestyramine. Summarize the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with cholestyramine. Access free multiple choice questions on this topic.", "contents": "Cholestyramine Resin  -- Continuing Education Activity. Objectives: Identify the mechanism of action of cholestyramine. Outline the approved and potential indications of cholestyramine. Recall the potential side effects/adverse events of cholestyramine. Summarize the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with cholestyramine. Access free multiple choice questions on this topic."}
{"id": "article-71_2", "title": "Cholestyramine Resin  -- Indications -- Cholestyramine Primary Indications", "content": "Used for patient treatment of primary hypercholesterolemia. The reduction in LDL Cholesterol by the\u00a0resin\u00a0is dose-dependent. A dose of 8-12 gram of Cholestyramine is associated with a 12%\u00a0to 18% reduction in LDL-Cholesterol. One to two weeks is adequate to attain maximal LDL-Cholesterol reduction. A maximal dose of cholestyramine (24 gram) may reduce LDL cholesterol\u00a0by as much as 25%. However, this will also lead to gastrointestinal side effects, which are often not well tolerated. [1] Pruritus can occur in patients with cholestatic disease and incomplete biliary obstruction. Cholestyramine, in doses of 4 grams, one to three times daily, is effective in 80% of the cases. [2]", "contents": "Cholestyramine Resin  -- Indications -- Cholestyramine Primary Indications. Used for patient treatment of primary hypercholesterolemia. The reduction in LDL Cholesterol by the\u00a0resin\u00a0is dose-dependent. A dose of 8-12 gram of Cholestyramine is associated with a 12%\u00a0to 18% reduction in LDL-Cholesterol. One to two weeks is adequate to attain maximal LDL-Cholesterol reduction. A maximal dose of cholestyramine (24 gram) may reduce LDL cholesterol\u00a0by as much as 25%. However, this will also lead to gastrointestinal side effects, which are often not well tolerated. [1] Pruritus can occur in patients with cholestatic disease and incomplete biliary obstruction. Cholestyramine, in doses of 4 grams, one to three times daily, is effective in 80% of the cases. [2]"}
{"id": "article-71_3", "title": "Cholestyramine Resin  -- Indications -- Other Clinical Applications", "content": "Cholestyramine has\u00a0been shown to decrease cardiovascular mortality and morbidity by 19% compared to placebo in patients with hypercholesterolemia as per the Lipid Research Clinic Coronary Primary Prevention Trial. Per the trial, the reduction in total cholesterol and LDL levels correlates to the decrease in the risk of coronary artery disease. [3]", "contents": "Cholestyramine Resin  -- Indications -- Other Clinical Applications. Cholestyramine has\u00a0been shown to decrease cardiovascular mortality and morbidity by 19% compared to placebo in patients with hypercholesterolemia as per the Lipid Research Clinic Coronary Primary Prevention Trial. Per the trial, the reduction in total cholesterol and LDL levels correlates to the decrease in the risk of coronary artery disease. [3]"}
{"id": "article-71_4", "title": "Cholestyramine Resin  -- Indications -- Other Clinical Applications", "content": "A randomized, double-blind crossover study with 21 patients performed by Garg et al. showed that cholestyramine had a glucose-lowering effect when used in individuals with dyslipidemia and type 2 Diabetes mellitus. The study showed a 13% decrease in plasma glucose levels in patients after using 8 grams of cholestyramine twice daily for six weeks. [3] [4]", "contents": "Cholestyramine Resin  -- Indications -- Other Clinical Applications. A randomized, double-blind crossover study with 21 patients performed by Garg et al. showed that cholestyramine had a glucose-lowering effect when used in individuals with dyslipidemia and type 2 Diabetes mellitus. The study showed a 13% decrease in plasma glucose levels in patients after using 8 grams of cholestyramine twice daily for six weeks. [3] [4]"}
{"id": "article-71_5", "title": "Cholestyramine Resin  -- Indications -- Other Clinical Applications", "content": "Cholestyramine can\u00a0be used in patients with bile-acid diarrhea or choleretic enteropathy due to limited ileal disease or resection. Diarrhea develops in these patients because of the stimulation of active chloride secretion by bile acids in the colon. However, cholestyramine is not helpful in patients with extensive ileal disease and/or resection presenting with fatty acid diarrhea. In extensive ileal disease or resection, the body cannot produce sufficient quantities of bile acid to compensate for the increased loss due to extensive bowel loss, leading to impaired micelle formation and steatorrhea.", "contents": "Cholestyramine Resin  -- Indications -- Other Clinical Applications. Cholestyramine can\u00a0be used in patients with bile-acid diarrhea or choleretic enteropathy due to limited ileal disease or resection. Diarrhea develops in these patients because of the stimulation of active chloride secretion by bile acids in the colon. However, cholestyramine is not helpful in patients with extensive ileal disease and/or resection presenting with fatty acid diarrhea. In extensive ileal disease or resection, the body cannot produce sufficient quantities of bile acid to compensate for the increased loss due to extensive bowel loss, leading to impaired micelle formation and steatorrhea."}
{"id": "article-71_6", "title": "Cholestyramine Resin  -- Indications -- Other Clinical Applications", "content": "Studies and case reports show the effectiveness of cholestyramine as an adjunct therapy to antithyroid medications for refractory thyrotoxicosis, leading to a more rapid reduction in serum thyroid hormone levels. However, the effect of cholestyramine is confined to a short period, and the long-term efficacy of the drug remains unclear.", "contents": "Cholestyramine Resin  -- Indications -- Other Clinical Applications. Studies and case reports show the effectiveness of cholestyramine as an adjunct therapy to antithyroid medications for refractory thyrotoxicosis, leading to a more rapid reduction in serum thyroid hormone levels. However, the effect of cholestyramine is confined to a short period, and the long-term efficacy of the drug remains unclear."}
{"id": "article-71_7", "title": "Cholestyramine Resin  -- Indications -- Other Clinical Applications", "content": "The inhibition of enterohepatic circulation by cholestyramine makes it an effective drug in the management of hyperthyroidism due to thyroiditis and factitious thyroid hormone use. [5] [6]", "contents": "Cholestyramine Resin  -- Indications -- Other Clinical Applications. The inhibition of enterohepatic circulation by cholestyramine makes it an effective drug in the management of hyperthyroidism due to thyroiditis and factitious thyroid hormone use. [5] [6]"}
{"id": "article-71_8", "title": "Cholestyramine Resin  -- Mechanism of Action", "content": "Cholestyramine is a large cationic exchange resin polymer. It is\u00a0insoluble in water.", "contents": "Cholestyramine Resin  -- Mechanism of Action. Cholestyramine is a large cationic exchange resin polymer. It is\u00a0insoluble in water."}
{"id": "article-71_9", "title": "Cholestyramine Resin  -- Mechanism of Action", "content": "Bile acids, metabolites of cholesterol, are normally efficiently reabsorbed in the jejunum and ileum. Excretion is increased up to tenfold when cholestyramine is given, resulting in the enhanced conversion of cholesterol to bile acids in the liver via 7a-hydroxylation, which is normally controlled by negative feedback by bile acids.", "contents": "Cholestyramine Resin  -- Mechanism of Action. Bile acids, metabolites of cholesterol, are normally efficiently reabsorbed in the jejunum and ileum. Excretion is increased up to tenfold when cholestyramine is given, resulting in the enhanced conversion of cholesterol to bile acids in the liver via 7a-hydroxylation, which is normally controlled by negative feedback by bile acids."}
{"id": "article-71_10", "title": "Cholestyramine Resin  -- Mechanism of Action", "content": "Increased uptake of LDL cholesterol and IDL from plasma results from the upregulation of the LDL receptors, particularly in the liver. Therefore, the bile acid resins, including cholestyramine, are not helpful in patients with homozygous familial hypercholesterolemia, who have no functioning receptors.", "contents": "Cholestyramine Resin  -- Mechanism of Action. Increased uptake of LDL cholesterol and IDL from plasma results from the upregulation of the LDL receptors, particularly in the liver. Therefore, the bile acid resins, including cholestyramine, are not helpful in patients with homozygous familial hypercholesterolemia, who have no functioning receptors."}
{"id": "article-71_11", "title": "Cholestyramine Resin  -- Mechanism of Action", "content": "Decreased activation of the farnesoid X receptor (FXR receptor) by bile acids may result in a modest increase in plasma triglycerides but can also improve glucose metabolism in patients with diabetes. The latter effect is due to the increased secretion of the incretin glucagon-like peptide-1 (GLP-1) from the intestine, thus increasing insulin secretion.", "contents": "Cholestyramine Resin  -- Mechanism of Action. Decreased activation of the farnesoid X receptor (FXR receptor) by bile acids may result in a modest increase in plasma triglycerides but can also improve glucose metabolism in patients with diabetes. The latter effect is due to the increased secretion of the incretin glucagon-like peptide-1 (GLP-1) from the intestine, thus increasing insulin secretion."}
{"id": "article-71_12", "title": "Cholestyramine Resin  -- Mechanism of Action", "content": "Cholestyramine also interferes with the metabolism of thyroid hormone. Thyroid hormone is metabolized mainly in the liver, where it is conjugated to glucuronides and sulfates. These conjugation products then enter the enterohepatic circulation by excretion into the bile. A fraction of conjugated products are deconjugated in the intestine, and free hormones are reabsorbed. In states of thyrotoxicosis, there is increased enterohepatic circulation of thyroid hormone. Cholestyramine decreases the reabsorption of thyroid hormone from enterohepatic circulation. [5] [6]", "contents": "Cholestyramine Resin  -- Mechanism of Action. Cholestyramine also interferes with the metabolism of thyroid hormone. Thyroid hormone is metabolized mainly in the liver, where it is conjugated to glucuronides and sulfates. These conjugation products then enter the enterohepatic circulation by excretion into the bile. A fraction of conjugated products are deconjugated in the intestine, and free hormones are reabsorbed. In states of thyrotoxicosis, there is increased enterohepatic circulation of thyroid hormone. Cholestyramine decreases the reabsorption of thyroid hormone from enterohepatic circulation. [5] [6]"}
{"id": "article-71_13", "title": "Cholestyramine Resin  -- Administration", "content": "Cholestyramine is available as a granular preparation. Cholestyramine should ideally be taken with breakfast when it is given to treat pruritus associated with cholestasis. Symptoms of pruritus are less frequent in the morning as it is believed that\u00a0the pruritogenic factors are concentrated in the gallbladder during overnight fasting. Most patients with chronic cholestasis and partial biliary obstruction will notice some\u00a0relief of their symptoms after a week of therapy. If not, another\u00a04-gram\u00a0dose may be given after breakfast. Additional doses, if needed, can be taken with meals 2\u00a0or 3 times daily; the response with additional doses is not marked. The lowest possible dose that controls pruritus should be used. Care should be exercised when taking other medications that can potentially mix with cholestyramine, leading to diminished efficacy. The maintenance dose is usually 4 grams/day, but the effective dose for treatment of cholestasis ranges from 4 to 16 grams/day.", "contents": "Cholestyramine Resin  -- Administration. Cholestyramine is available as a granular preparation. Cholestyramine should ideally be taken with breakfast when it is given to treat pruritus associated with cholestasis. Symptoms of pruritus are less frequent in the morning as it is believed that\u00a0the pruritogenic factors are concentrated in the gallbladder during overnight fasting. Most patients with chronic cholestasis and partial biliary obstruction will notice some\u00a0relief of their symptoms after a week of therapy. If not, another\u00a04-gram\u00a0dose may be given after breakfast. Additional doses, if needed, can be taken with meals 2\u00a0or 3 times daily; the response with additional doses is not marked. The lowest possible dose that controls pruritus should be used. Care should be exercised when taking other medications that can potentially mix with cholestyramine, leading to diminished efficacy. The maintenance dose is usually 4 grams/day, but the effective dose for treatment of cholestasis ranges from 4 to 16 grams/day."}
{"id": "article-71_14", "title": "Cholestyramine Resin  -- Administration", "content": "Although cholestyramine lowers serum bile acid levels by inhibiting the reabsorption of bile acids from the small bowel, other bile acid sequestrants such as colesevelam do not relieve pruritus in cholestasis. Thus binding of other pruritogens, stimulating the release of other endogenous anti-opioid agents such as cholecystokinin might explain why cholestyramine is effective in the relief of pruritus in other non-cholestatic disorders such as polycythemia vera and uremia.", "contents": "Cholestyramine Resin  -- Administration. Although cholestyramine lowers serum bile acid levels by inhibiting the reabsorption of bile acids from the small bowel, other bile acid sequestrants such as colesevelam do not relieve pruritus in cholestasis. Thus binding of other pruritogens, stimulating the release of other endogenous anti-opioid agents such as cholecystokinin might explain why cholestyramine is effective in the relief of pruritus in other non-cholestatic disorders such as polycythemia vera and uremia."}
{"id": "article-71_15", "title": "Cholestyramine Resin  -- Adverse Effects", "content": "Common adverse effects are dyspepsia and bloating. These symptoms can be decreased if cholestyramine is completely suspended in liquid several hours before ingestion. [7]", "contents": "Cholestyramine Resin  -- Adverse Effects. Common adverse effects are dyspepsia and bloating. These symptoms can be decreased if cholestyramine is completely suspended in liquid several hours before ingestion. [7]"}
{"id": "article-71_16", "title": "Cholestyramine Resin  -- Adverse Effects", "content": "Constipation is a common side effect that is\u00a0preventable with adequate water and fiber intake.", "contents": "Cholestyramine Resin  -- Adverse Effects. Constipation is a common side effect that is\u00a0preventable with adequate water and fiber intake."}
{"id": "article-71_17", "title": "Cholestyramine Resin  -- Adverse Effects", "content": "Decreased palatability due to gritty sensation from drinking the powdered solution of cholestyramine.", "contents": "Cholestyramine Resin  -- Adverse Effects. Decreased palatability due to gritty sensation from drinking the powdered solution of cholestyramine."}
{"id": "article-71_18", "title": "Cholestyramine Resin  -- Adverse Effects", "content": "Cholestyramine is considered a safe medication since it is not systemically absorbed. However, in rare instances, such as in patients with renal insufficiency and patients on aldosterone antagonists such as spironolactone, it is known to cause hyperchloremic metabolic acidosis.", "contents": "Cholestyramine Resin  -- Adverse Effects. Cholestyramine is considered a safe medication since it is not systemically absorbed. However, in rare instances, such as in patients with renal insufficiency and patients on aldosterone antagonists such as spironolactone, it is known to cause hyperchloremic metabolic acidosis."}
{"id": "article-71_19", "title": "Cholestyramine Resin  -- Adverse Effects", "content": "Cholestyramine is a cationic resin that exchanges chloride anions for bile acids in the lumen of the small intestine, resulting in fecal excretion of bile acids. The chloride and bicarbonate anti-porter present at the apical brush border of the duodenum causes increased absorption of chloride and secretion of bicarbonate, leading to hyperchloremic metabolic acidosis. This effect is more pronounced in patients with impaired urinary acidification due to renal insufficiency and medications such as spironolactone since there is no adequate renal compensation. [8]", "contents": "Cholestyramine Resin  -- Adverse Effects. Cholestyramine is a cationic resin that exchanges chloride anions for bile acids in the lumen of the small intestine, resulting in fecal excretion of bile acids. The chloride and bicarbonate anti-porter present at the apical brush border of the duodenum causes increased absorption of chloride and secretion of bicarbonate, leading to hyperchloremic metabolic acidosis. This effect is more pronounced in patients with impaired urinary acidification due to renal insufficiency and medications such as spironolactone since there is no adequate renal compensation. [8]"}
{"id": "article-71_20", "title": "Cholestyramine Resin  -- Contraindications", "content": "Cholestyramine is contraindicated in cases of severe hypertriglyceridemia and complete biliary obstruction. [7]", "contents": "Cholestyramine Resin  -- Contraindications. Cholestyramine is contraindicated in cases of severe hypertriglyceridemia and complete biliary obstruction. [7]"}
{"id": "article-71_21", "title": "Cholestyramine Resin  -- Toxicity", "content": "Interference with the absorption of fat-soluble vitamins such as vitamin K can lead to derangements in clotting factors. Patients may require supplementation of fat-soluble vitamins, especially if they are on long-term cholestyramine therapy.", "contents": "Cholestyramine Resin  -- Toxicity. Interference with the absorption of fat-soluble vitamins such as vitamin K can lead to derangements in clotting factors. Patients may require supplementation of fat-soluble vitamins, especially if they are on long-term cholestyramine therapy."}
{"id": "article-71_22", "title": "Cholestyramine Resin  -- Toxicity", "content": "Cholestyramine can interfere with the absorption of many medications such as digitalis glycosides, propranolol, thiazides, warfarin, tetracycline, thyroxine, iron salts, statins (pravastatin and fluvastatin), ezetimibe, phenobarbital, non-steroidal anti-inflammatory medications, loperamide, and tricyclic antidepressants. Due to drug interactions, it is advised to administer other medications 1 hour before or 4 hours after taking cholestyramine. [9]", "contents": "Cholestyramine Resin  -- Toxicity. Cholestyramine can interfere with the absorption of many medications such as digitalis glycosides, propranolol, thiazides, warfarin, tetracycline, thyroxine, iron salts, statins (pravastatin and fluvastatin), ezetimibe, phenobarbital, non-steroidal anti-inflammatory medications, loperamide, and tricyclic antidepressants. Due to drug interactions, it is advised to administer other medications 1 hour before or 4 hours after taking cholestyramine. [9]"}
{"id": "article-71_23", "title": "Cholestyramine Resin  -- Enhancing Healthcare Team Outcomes", "content": "Cholestyramine\u00a0has been around for over half a century. Most clinicians, sadly, do not know that\u00a0is it a useful therapeutic agent for the treatment of both hypercholesterolemia and pruritus.\u00a0Clinicians who have patients with chronic pruritus should be familiar with this agent as it can improve the quality of life. Primary caregivers, nurse practitioners, internists, and other clinicians who\u00a0treat patients with liver failure may find the drug useful for managing pruritus. Nurses can provide patient counseling regarding potential adverse events and dosing and serve as a primary contact point between the patient and prescribing clinician. Cholestyramine is a relatively safe drug, but patients need to be educated on how to use it for maximal efficiency and prevention of drug interactions. For those healthcare workers who would like to use the drug, the pharmacist is the ideal person to provide more practical details on dosage and duration. [10] [11] These examples of interprofessional teamwork will lead to improved outcomes when using cholestyramine when indicated and help minimize any potential adverse effects. [Level 5]", "contents": "Cholestyramine Resin  -- Enhancing Healthcare Team Outcomes. Cholestyramine\u00a0has been around for over half a century. Most clinicians, sadly, do not know that\u00a0is it a useful therapeutic agent for the treatment of both hypercholesterolemia and pruritus.\u00a0Clinicians who have patients with chronic pruritus should be familiar with this agent as it can improve the quality of life. Primary caregivers, nurse practitioners, internists, and other clinicians who\u00a0treat patients with liver failure may find the drug useful for managing pruritus. Nurses can provide patient counseling regarding potential adverse events and dosing and serve as a primary contact point between the patient and prescribing clinician. Cholestyramine is a relatively safe drug, but patients need to be educated on how to use it for maximal efficiency and prevention of drug interactions. For those healthcare workers who would like to use the drug, the pharmacist is the ideal person to provide more practical details on dosage and duration. [10] [11] These examples of interprofessional teamwork will lead to improved outcomes when using cholestyramine when indicated and help minimize any potential adverse effects. [Level 5]"}
{"id": "article-71_24", "title": "Cholestyramine Resin  -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cholestyramine Resin  -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}